Company intelligence / Profile preview

BioCam

Wroclaw, Dolnoslaskie, Polandbiocam.ai ↗

Ownership: Private
Employees: ~28
Development stage: Preclinical

Overview

BioCam has developed a non-invasive, AI-powered endoscopic capsule system for gastrointestinal imaging and diagnosis. The system enables real-time detection of abnormalities throughout the digestive tract, with supporting telemedicine and mobile applications to facilitate remote diagnostics and patient management. The technology is designed to improve patient comfort, accessibility, and diagnostic accuracy for GI diseases.

Therapeutic areas: GastroenterologyOncologyHematology
Modalities: Device (endoscopic capsule)Artificial intelligence-powered software
Industry: Medical Imaging

Partnerships

Flyps (collaborator on AI/software development)

Beyond the preview

Go deeper on BioCam.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioCam.

Explore the full profile